Vista Pharmaceuticals Limited

BSE:524711 Stock Report

Market Cap: ₹898.3m

Vista Pharmaceuticals Management

Management criteria checks 2/4

Vista Pharmaceuticals' CEO is Murali Meraga, appointed in Oct 2022, has a tenure of 2.17 years. directly owns 11.71% of the company’s shares, worth ₹105.21M. The average tenure of the management team and the board of directors is 2.2 years and 4.8 years respectively.

Key information

Murali Meraga

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.2yrs
CEO ownership11.7%
Management average tenure2.2yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO

Murali Meraga

2.2yrs

Tenure

Mr. Murali Meraga served as Non-Executive Director of Vista Pharmaceuticals Limited from October 2022 until October 14, 2022 and serves as its Managing Director and Executive Director since October 14, 202...

Leadership Team

NamePositionTenureCompensationOwnership
Dhananjaya Alli
Chairman and Whole-Time Director of Science & Technology30yrsno data3.76%
₹ 33.8m
Murali Meraga
MD & Executive Director2.2yrsno data11.71%
₹ 105.2m
Pavan Gilaka
Whole-Time Director2.2yrsno data10.1%
₹ 90.7m
Suneel Pachipala
Chief Financial Officer9.7yrs₹600.00kno data
Barkha Jain
Company Secretary & Compliance Officerless than a yearno datano data

2.2yrs

Average Tenure

Experienced Management: 524711's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dhananjaya Alli
Chairman and Whole-Time Director of Science & Technology30yrsno data3.76%
₹ 33.8m
Murali Meraga
MD & Executive Director2.2yrsno data11.71%
₹ 105.2m
Pavan Gilaka
Whole-Time Director2.2yrsno data10.1%
₹ 90.7m
Stanley Reddy
Non-Executive Director8.3yrsno datano data
Mallem Rao
Non Executive Director15.4yrsno data0.0012%
₹ 10.5k
Divya Chakravarthula
Non-Executive Independent Director6.8yrsno datano data
Umesh Banakar
Non-Executive Independent Director6.8yrsno datano data
Divakar Yerrabommanahalli
Non Executive Director5.3yrsno datano data
Umakanth Katta
Non Executive Director4.4yrsno data9.94%
₹ 89.3m
Naga Madineni
Independent Director1.2yrsno datano data
Anumala Chandrakumar
Independent Director1.2yrsno datano data
Madhu Anchi
Independent Director1.2yrsno datano data

4.8yrs

Average Tenure

67.5yo

Average Age

Experienced Board: 524711's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 11:57
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vista Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution